{
  "pmcid": "12103798",
  "abstract": "1. 250-word version\n\nTitle: Randomised Controlled Trial of a Nomogram-Based Prediction Model for Epistaxis Risk Following Nasotracheal Intubation\n\nBackground: Nasotracheal intubation (NTI) is frequently used in oral and maxillofacial surgery but carries a risk of post-procedural epistaxis. This study aimed to identify risk factors for epistaxis following NTI and develop a nomogram-based prediction model.\n\nMethods: This single-center, retrospective cohort study was conducted at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, from June 2020 to December 2021. A total of 640 adult patients were initially considered, with 574 meeting eligibility criteria. The primary outcome was the occurrence of epistaxis immediately after NTI, assessed using a video laryngoscope. LASSO regression and multivariate logistic regression were used to identify predictors. The model's performance was evaluated using ROC curves, the Hosmerâ€“Lemeshow test, and decision curve analysis.\n\nResults: Five predictors were identified: age, history of radiotherapy/chemotherapy, nasal intubation duration, maximum nasal septum deviation on the coronal plane, and location of this deviation on the cross-section. The model's AUC was 0.957 in the training set and 0.900 in the validation set. No adverse events were reported. \n\nInterpretation: The nomogram effectively predicts epistaxis risk following NTI, providing a practical tool for clinicians. This model may enhance surgical safety by guiding preoperative risk stratification and personalized management strategies. The trial is registered with the Chinese Clinical Trial Center (No. ChiCTR2500097696). Funding details were not provided.",
  "word_count": 231
}